Works matching DE "BOCEPREVIR"

Results: 117

Pharmacokinetic interaction between HCV protease inhibitor boceprevir and methadone or buprenorphine in subjects on stable maintenance therapy.

Published in:

European Journal of Clinical Pharmacology, 2015, v. 71, n. 3, p. 303, doi. 10.1007/s00228-014-1789-4

By:

Hulskotte, Ellen;
Bruce, R.;
Feng, Hwa-Ping;
Webster, Lynn;
Xuan, Feng;
Lin, Wen;
O'Mara, Edward;
Wagner, John;
Butterton, Joan

Publication type:

Article

Pharmacokinetic and pharmacodynamic interactions between the hepatitis C virus protease inhibitor, boceprevir, and the oral contraceptive ethinyl estradiol/norethindrone.

Published in:

European Journal of Clinical Pharmacology, 2014, v. 70, n. 9, p. 1107, doi. 10.1007/s00228-014-1711-0

By:

Lin, Wen;
Feng, Hwa-Ping;
Shadle, Craig;
O'Reilly, Terry;
Wagner, John;
Butterton, Joan

Publication type:

Article

New Therapies for Hepatitis C: Considerations in Patients with Renal Impairment.

Published in:

2014

By:

Zimner-Rapuch, Sarah;
Janus, Nicolas;
Deray, Gilbert;
Launay-Vacher, Vincent

Publication type:

Journal Article

Boceprevir.

Published in:

2012

By:

Garnock-Jones, Karly P.

Publication type:

Journal Article

Boceprevir for chronic HCV genotype 1 infection in treatment-experienced patients with severe fibrosis or cirrhosis: The Greek real-life experience.

Published in:

Annals of Gastroenterology, 2015, v. 28, n. 4, p. 481

By:

Manolakopoulos, Spilios;
Kranidioti, Hariklia;
Goulis, John;
Vlachogiannakos, John;
Elefsiniotis, John;
Kouroumalis, Elias A.;
Koskinas, John;
Kontos, George;
Evangelidou, Eftychia;
Doumba, Polyxeni;
Sinakos, Emmanuel;
Vafiadou, lrini;
Koulentaki, Mairi;
Papatheodoridis, George;
Akriviadis, Evangelos

Publication type:

Article

Boceprevir-Based Triple Antiviral Therapy for Chronic Hepatitis C Virus Infection in Kidney-Transplant Candidates.

Published in:

Journal of Transplantation, 2015, v. 2015, p. 1, doi. 10.1155/2015/159795

By:

Mehawej, Mireille;
Rostaing, Lionel;
Alric, Laurent;
Del Bello, Arnaud;
Izopet, Jacques;
Kamar, Nassim

Publication type:

Article

Over-expression and characterization of NS3 and NS5A of Hepatitis C virus genotype 3a.

Published in:

Microbial Cell Factories, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1475-2859-12-111

By:

Anwar, Muhammad Ikram;
Iqbal, Mazhar;
Yousef, Mohammad S.;
Rahman, Moazur

Publication type:

Article

A Phase I study to assess the safety, tolerability and pharmacokinetic profile of boceprevir and sildenafil when dosed separately and together, in healthy male volunteers.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 6, p. 1812, doi. 10.1093/jac/dkv035

By:

Mora-Peris, Borja;
Else, Laura;
Goldmeier, David;
Mears, Alison;
Weston, Rosy;
Cooke, Graham;
Khoo, Saye;
Back, David;
Winston, Alan

Publication type:

Article

Pharmacokinetics of the co-administration of boceprevir and St John's wort to male and female healthy volunteers.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 7, p. 1911, doi. 10.1093/jac/dku060

By:

Jackson, Akil;
D'Avolio, Antonio;
Moyle, Graeme;
Bonora, Stefano;
Di Perri, Giovanni;
Else, Laura;
Simiele, Marco;
Singh, Gurmit Jagjit;
Back, David;
Boffito, Marta

Publication type:

Article

Lack of a clinically significant drug–drug interaction in healthy volunteers between the HCV protease inhibitor boceprevir and the proton pump inhibitor omeprazole.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 6, p. 1415, doi. 10.1093/jac/dkt032

By:

de Kanter, Clara T. M. M.;
Colbers, Angela P. H.;
Blonk, Maren I.;
Verweij-van Wissen, Corrien P. W. G. M.;
Schouwenberg, Bas J. J. W.;
Drenth, Joost P. H.;
Burger, David M.

Publication type:

Article

Spontaneous Household Medicine Returns in the Brazilian Public Health System (Minas Gerais): Characterization and Legal Overview About Reverse Logistics.

Published in:

Journal of Solid Waste Technology & Management, 2016, v. 42, n. 1, p. 621

By:

Pereira, Andre;
de Vasconcelos Barros, Raphael Tobias;
Pereira, Sandra Rosa

Publication type:

Article

Clinical Implications of Detectable Baseline Hepatitis C Virus-Genotype 1 NS3/4A-Protease Variants on the Efficacy of Boceprevir Combined With Peginterferon/Ribavirin.

Published in:

Open Forum Infectious Diseases, 2014, v. 1, n. 2, p. 1, doi. 10.1093/ofid/ofu078

By:

Howe, John A.;
Long, Jianmin;
Black, Stuart;
Chase, Robert;
McMonagle, Patricia;
Curry, Stephanie;
Thompson, Seth;
DiNubile, Mark J.;
Howe, Anita Y. M.

Publication type:

Article

Liver transplantation in a child with multifocal hepatocellular carcinoma hepatitis C and management of post-transplant viral recurrence using boceprevir.

Published in:

Pediatric Transplantation, 2014, v. 18, n. 2, p. E64, doi. 10.1111/petr.12223

By:

Malik, Saloni;
Dekio, Fumiko;
Wen, Jessica W.

Publication type:

Article

Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake.

Published in:

HIV Medicine, 2015, v. 16, n. 10, p. 599, doi. 10.1111/hiv.12269

By:

Schaerer, V;
Haubitz, S;
Kovari, H;
Ledergerber, B;
Ambrosioni, J;
Cavassini, M;
Stoeckle, M;
Schmid, P;
Decosterd, L;
Aouri, M;
Böni, J;
Günthard, HF;
Furrer, H;
Metzner, KJ;
Fehr, J;
Rauch, A

Publication type:

Article

Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir.

Published in:

Alimentary Pharmacology & Therapeutics, 2015, v. 41, n. 7, p. 671, doi. 10.1111/apt.13095

By:

Sterling, R. K.;
Kuo, A.;
Rustgi, V. K.;
Sulkowski, M. S.;
Stewart, T. G.;
Fenkel, J. M.;
El‐Genaidi, H.;
Mah'moud, M. A.;
Abraham, G. M.;
Stewart, P. W.;
Akushevich, L.;
Nelson, D. R.;
Fried, M. W.;
Di Bisceglie, A. M.

Publication type:

Article

Telaprevir or boceprevir triple therapy in patients with chronic hepatitis C and varying severity of cirrhosis.

Published in:

Alimentary Pharmacology & Therapeutics, 2014, v. 39, n. 10, p. 1213, doi. 10.1111/apt.12718

By:

Saxena, V.;
Manos, M. M.;
Yee, H. S.;
Catalli, L.;
Wayne, E.;
Murphy, R. C.;
Shvachko, V. A.;
Pauly, M. P.;
Chua, J.;
Monto, A.;
Terrault, N. A.

Publication type:

Article

Comparative effectiveness of the hepatitis C virus protease inhibitors boceprevir and telaprevir in a large U.S. cohort.

Published in:

Alimentary Pharmacology & Therapeutics, 2014, v. 39, n. 1, p. 93, doi. 10.1111/apt.12546

By:

Backus, L. I.;
Belperio, P. S.;
Shahoumian, T. A.;
Cheung, R.;
Mole, L. A.

Publication type:

Article

Efficacy and safety profile of boceprevir- or telaprevir-based triple therapy or dual peginterferon alfa-2a or alfa-2b plus ribavirin therapy in chronic hepatitis C: the real-world PegBase observational study.

Published in:

Annals of Gastroenterology, 2017, v. 30, n. 3, p. 327, doi. 10.20524/aog.2017.0136

By:

Mangia, Alessandra;
Foster, Graham R.;
Berg, Christoph P.;
Curescu, Manuela;
De Ledinghen, Victor;
Habersetzer, François;
Manolakopoulos, Spilios;
Negri, Elisa;
Papatheodoridis, George;
Ahlers, Silke;
Castillo, Marco;
Bakalos, Georgios;
Mauss, Stefan

Publication type:

Article

Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy.

Published in:

PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0125080

By:

Neukam, Karin;
Munteanu, Daniela I.;
Rivero-Juárez, Antonio;
Lutz, Thomas;
Fehr, Jan;
Mandorfer, Mattias;
Bhagani, Sanjay;
López-Cortés, Luis F.;
Haberl, Annette;
Stoeckle, Marcel;
Márquez, Manuel;
Scholten, Stefan;
de los Santos-Gil, Ignacio;
Mauss, Stefan;
Rivero, Antonio;
Collado, Antonio;
Delgado, Marcial;
Rockstroh, Juergen K.;
Pineda, Juan A.

Publication type:

Article

Individualized Treatment of Genotype 1 Naïve Patients: An Italian Multicenter Field Practice Experience.

Published in:

PLoS ONE, 2014, v. 9, n. 10, p. 1, doi. 10.1371/journal.pone.0110284

By:

Mangia, Alessandra;
Cenderello, Giovanni;
Orlandini, Alessandra;
Piazzolla, Valeria;
Picciotto, Antonio;
Zuin, Massimo;
Ciancio, Alessia;
Brancaccio, Giuseppina;
Forte, Paolo;
Carretta, Vito;
Zignego, Anna Linda;
Minerva, Nicola;
Brindicci, Gaetano;
Marignani, Massimo;
Baroni, Gianluca Svegliati;
Bertino, Gaetano;
Cuccorese, Giuseppe;
Mottola, Leonardo;
Ripoli, Maria;
Pirisi, Mario

Publication type:

Article

Prediction of Treatment Week Eight Response & Sustained Virologic Response in Patients Treated with Boceprevir Plus Peginterferon Alfa and Ribavirin.

Published in:

PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0103370

By:

Thompson, Alex;
Devine, Scott;
Kattan, Mike;
Muir, Andrew

Publication type:

Article

Peg-Interferon Plus Ribavirin with or without Boceprevir or Telaprevir for HCV Genotype 1: A Meta-Analysis on the Role of Response Predictors.

Published in:

PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0094542

By:

Coppola, Nicola;
Pisaturo, Mariantonietta;
Sagnelli, Caterina;
Sagnelli, Evangelista;
Angelillo, Italo F.

Publication type:

Article

Eligibility and Safety of Triple Therapy for Hepatitis C: Lessons Learned from the First Experience in a Real World Setting.

Published in:

PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0055285

By:

Maasoumy, Benjamin;
Port, Kerstin;
Markova, Antoaneta Angelova;
Serrano, Beatriz Calle;
Rogalska-Taranta, Magdalena;
Sollik, Lisa;
Mix, Carola;
Kirschner, Janina;
Manns, Michael P.;
Wedemeyer, Heiner;
Cornberg, Markus

Publication type:

Article

Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study.

Published in:

BMC Infectious Diseases, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2334-13-190

By:

Ferrante, Shannon Allen;
Chhatwal, Jagpreet;
Brass, Clifford A.;
Khoury, Antoine C. El;
Poordad, Fred;
Bronowicki, Jean-Pierre;
Elbasha, Elamin H.

Publication type:

Article

Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirin.

Published in:

Alimentary Pharmacology & Therapeutics, 2013, v. 38, n. 1, p. 16, doi. 10.1111/apt.12342

By:

Gordon, S. C.;
Yoshida, E. M.;
Lawitz, E. J.;
Bacon, B. R.;
Sulkowski, M. S.;
Davis, M.;
Poordad, F.;
Bronowicki, J.‐P.;
Esteban, R.;
Sniukiene, V.;
Burroughs, M. H.;
Deng, W.;
Dutko, F. J.;
Brass, C. A.;
Albrecht, J. K.;
Rajender Reddy, K.

Publication type:

Article

Cost-Effectiveness Analysis of Triple Therapy with Protease Inhibitors in Treatment-Naive Hepatitis C Patients.

Published in:

PharmacoEconomics, 2013, v. 31, n. 10, p. 919, doi. 10.1007/s40273-013-0080-3

By:

Blázquez-Pérez, Antonio;
San Miguel, Ramón;
Mar, Javier

Publication type:

Article

Hepatitis C.

Published in:

JAMA: Journal of the American Medical Association, 2014, v. 312, n. 6, p. 664, doi. 10.1001/jama.2013.281899

By:

Tolmach Sugerman, Deborah

Publication type:

Article

Boceprevir Contraindications.

Published in:: JAMA: Journal of the American Medical Association, 2014, v. 311, n. 8, p. 791, doi. 10.1001/jama.2014.1337
Publication type:: Article

Rapid virological response of telaprevir and boceprevir in a Brazilian cohort of HCV genotype 1 patients: a multicenter longitudinal study.

Published in:

2017

By:

Borba, Helena H. L.;
Wiens, Astrid;
Steimbach, Laiza M.;
Tonin, Fernanda S.;
Pedroso, Maria L. A.;
Ivantes, Cláudia A. P.;
Fernandez-Llimos, Fernando;
Pontarolo, Roberto;
Borba, Helena Hl;
Pedroso, Maria LA;
Ivantes, Cláudia Ap

Publication type:

journal article

Antiviral Medications, Part 4: Evidence-Based Treatment of Hepatitis C.

Published in:

MEDSURG Nursing, 2018, v. 27, n. 1, p. 49

By:

Felicilda-Reynaldo, Rhea Faye D.

Publication type:

Article

Editorial Commentary: Management of Hepatitis C Virus in HIV-Infected Patients in the Era of Direct-Acting Antivirals.

Published in:

Clinical Infectious Diseases, 2014, v. 58, n. 6, p. 880, doi. 10.1093/cid/cit804

By:

Zeremski, Marija;
Martinez, Anthony D.;
Talal, Andrew H.

Publication type:

Article

Priapism Induced by Boceprevir-CYP3A4 Inhibition and α-Adrenergic Blockade: Case Report.

Published in:

Clinical Infectious Diseases, 2014, v. 58, n. 1, p. e35, doi. 10.1093/cid/cit673

By:

Hammond, Kyle P.;
Nielsen, Craig;
Linnebur, Sunny A.;
Langness, Jacob A.;
Ray, Graham;
Maroni, Paul;
Kiser, Jennifer J.

Publication type:

Article

Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs.

Published in:

Clinical Infectious Diseases, 2013, v. 57, n. Supp 2, p. S125, doi. 10.1093/cid/cit299

By:

Mauss, Stefan;
Klinker, Hartwig

Publication type:

Article

Drug–Drug Interactions and Drug Resistance Will Limit Access to Treatment in Patients With HIV and Hepatitis C Virus Coinfection.

Published in:

Clinical Infectious Diseases, 2013, v. 57, n. 1, p. 156, doi. 10.1093/cid/cit168

By:

Marks, Michael;
Kulasegaram, Ranjababu

Publication type:

Article

Closing in on the Target: Sustained Virologic Response in Hepatitis C Virus Genotype 1 Infection Response-Guided Therapy.

Published in:

Clinical Infectious Diseases, 2013, v. 56, n. 10, p. 1466, doi. 10.1093/cid/cit025

By:

Lontok, Erik;
Mani, Nina;
Harrington, Patrick R.;
Miller, Veronica

Publication type:

Article

Carlson A et al (Clin Infect Dis 2013; 56:552–4).

Published in:: 2013
Publication type:: Correction Notice

Telaprevir to Boceprevir Switch Highlights Lack of Cross-Reactivity.

Published in:

Clinical Infectious Diseases, 2013, v. 56, n. 4, p. 552, doi. 10.1093/cid/cis960

By:

Carlson, Amanda;
Gregorich, Zachery;
Striker, Rob

Publication type:

Article

Lack of a Clinically Significant Drug–Drug Interaction in Healthy Volunteers Between the Hepatitis C Virus Protease Inhibitor Boceprevir and the HIV Integrase Inhibitor Raltegravir.

Published in:

Clinical Infectious Diseases, 2013, v. 56, n. 2, p. 300, doi. 10.1093/cid/cis824

By:

de Kanter, Clara T. M. M.;
Blonk, Maren I.;
Colbers, Angela P. H.;
Schouwenberg, Bas J. J. W.;
Burger, David M.

Publication type:

Article

The Relative Efficacy of Boceprevir and Telaprevir in the Treatment of Hepatitis C Virus Genotype 1.

Published in:

Clinical Infectious Diseases, 2013, v. 56, n. 2, p. 228, doi. 10.1093/cid/cis880

By:

Kieran, Jennifer;
Schmitz, Susanne;
O'Leary, Aisling;
Walsh, Cathal;
Bergin, Colm;
Norris, Suzanne;
Barry, Michael

Publication type:

Article

THE NEW STANDARD OF CARE IN HCV TREATMENT.

Published in:

Johns Hopkins Advanced Studies in Medicine, 2014, v. 14, n. 1, p. 8

By:

Sulkowski, Mark

Publication type:

Article

Care management programs key to helping deal with complexities of hepatitis C medication adherence.

Published in:: Formulary, 2013, v. 48, n. 5, p. 1
Publication type:: Article

Boceprevir: A new oral protease inhibitor for the treatment of chronic hepatitis C.

Published in:

Formulary, 2011, v. 46, n. 9, p. 352

By:

Feret, Brett

Publication type:

Article

Cost-effectiveness of strategy-based approach to treatment of genotype 1 chronic hepatitis C.

Published in:

Journal of Gastroenterology & Hepatology, 2016, v. 31, n. 9, p. 1628, doi. 10.1111/jgh.13341

By:

Zhao, Ying Jiao;
Khoo, Ai Leng;
Lin, Liang;
Teng, Monica;
Koh, Calvin J;
Lim, Seng Gee;
Lim, Boon Peng;
Dan, Yock Young

Publication type:

Article

Successful Antiviral Triple Therapy in a Longstanding Refractory Hepatitis C Virus Infection with an Acute Kidney Injury.

Published in:

2014

By:

Monje, David Callau;
Braun, Niko;
Latus, Joerg;
Amann, Kerstin;
Alscher, Mark Dominik;
Kimmel, Martin

Publication type:

Case Study

Hepatitis C: why the low uptake of boceprevir and telaprevir?

Published in:

Prescriber, 2012, v. 23, n. 23/24, p. 6, doi. 10.1002/psb.992

By:

Gore, Charles

Publication type:

Article

Boceprevir and telaprevir: new treatments for chronic hepatitis C.

Published in:

Prescriber, 2012, v. 23, n. 23/24, p. 42, doi. 10.1002/psb.998

By:

Chaplin, Steve;
Dusheiko, Geoffrey

Publication type:

Article

Telaprevir or boceprevir in HIV/HCV-1 co-infected patients in a real-life setting. Interim analysis (24 weeks). COINFECOVA-SEICV study.

Published in:

Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19634

By:

Minguez, Carlos;
Ortega, Enrique;
Flores, Juan;
Carmena, Jorge;
Masiá, Mar;
Montero, Marta;
Reus, Sergio;
Tornero, Carlos;
Jose Galindo, Maria;
Garcia-Deltoro, Miguel;
Amador, Concepción;
María Cuadrado, Jose;
Usó, Jorge;
López-Aldeguer, Jose

Publication type:

Article

Antworten zu den Fragen zu «Therapie der chronischen Hepatitis C» aus PRAXIS Nr. 8.

Published in:: Praxis (16618157), 2014, v. 103, n. 9, p. 543, doi. 10.1024/1661-8157/a001619
Publication type:: Article

Hepatitis C Treatment: Improved Efficacy and Tolerability.

Published in:

South Dakota Medicine, 2014, v. 67, n. 10, p. 419

By:

Lemon, Michael

Publication type:

Article

Analysis of Naturally Occurring Resistance-Associated Variants to NS3/4A Protein Inhibitors, NS5A Protein Inhibitors, and NS5B Polymerase Inhibitors in Patients With Chronic Hepatitis C.

Published in:

Gene Expression (1052-2166), 2018, v. 18, n. 1, p. 63, doi. 10.3727/105221617X15100607143377

By:

Danhui Sun;
Mingjia Dai;
Shanshan Shen;
Chunyang Li;
Xuebing Yan

Publication type:

Article